Tilray Brands, Inc. (TLRY)

Tilray reported record net revenue of $217.5 million for Q2 Fiscal 2026, but posted a net loss of $(43.5) million. Tilray launched expanded "Dry January" offerings and established Tilray Medical USA, Inc. to leverage potential opportunities arising from U.S. federal cannabis rescheduling. Redecan introduced Amped Live Resin Liquid Diamond vape cartridges in Canada. Tilray Brands, Inc. executed a 1-for-10 reverse stock split. ATB Capital Markets upgraded Tilray Brands from a "strong sell" to a "hold" rating. The company held its first-quarter fiscal 2026 earnings call. TLRY shares have climbed 42.5% in the past six months.

Tilray Brands, Inc. experiences demand seasonality within its beverage and wellness segments. The company actively promotes "Dry January" offerings at the beginning of the calendar year, indicating a seasonal marketing strategy around this period. A "holiday consumption update" in November 2025 suggests that the demand for their beverage and wellness products may be influenced by holiday seasons. The company's focus on optimizing its price/pack/channel architecture and driving distribution also aims to enhance its relevance within home markets, potentially adapting to seasonal consumer trends.

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company that researches, cultivates, processes, and distributes medical and adult-use cannabis, craft beer, spirits, and various beverages. The company's beverage segment offers craft beer, spirits, non-alcoholic craft beer, sparkling waters under the Liquid Love brand, and clean-label energy drinks. In the cannabis space, Tilray produces medical and adult-use cannabis products, including hemp foods and Hemp Derived Delta-9 (HD-D9) beverages. Tilray also has a distribution segment involved in the resale of pharmaceutical and wellness products. Notable brands under Tilray include Aphria, Good Supply, Redecan, SweetWater Brewery, and Manitoba Harvest.

Tilray Brands, Inc. operates in over 20 countries across North America, Europe, and Latin America, including Canada, the United States, Australia, New Zealand, Germany, Portugal, Poland, Italy, the Middle East, and Africa. The company maintains growing facilities in Germany and Portugal and has a large pharmacy network across Europe for distributing medical cannabis, pharmaceuticals, and medical devices.

Tilray Brands is recognized as the cannabis market leader in Canada and a leader in medical cannabis across Europe, and is ranked as the fourth-largest craft beer brewer in the United States. Recent product innovations and strategic expansions contribute to its brand visibility and market positioning. The stock has occasionally experienced negative reactions, suggesting a pattern of "selling into good news." The company's Q2 fiscal 2026 earnings report highlighted margin pressures in its cannabis and consumer packaged goods (CPG) beverage segments.

Major institutional owners include Amplify ETF Trust - Amplify Alternative Harvest ETF, Toroso Investments, LLC, Hrt Financial Lp, Susquehanna International Group, Llp, Citadel Advisors Llc, Millennium Management Llc, Jane Street Group, Llc, and Vanguard Group Inc. Individual insider owners include Brendan Kennedy, who holds 7.75% of the company's shares, and Irwin D. Simon.